|
SBDSP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.239100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.364400E-03 |
| Normal-vs-Stage2 |
4.278800E-01 |
| Normal-vs-Stage3 |
3.025300E-04 |
| Normal-vs-Stage4 |
1.397950E-03 |
| Stage1-vs-Stage2 |
5.399400E-01 |
| Stage1-vs-Stage3 |
1.284020E-01 |
| Stage1-vs-Stage4 |
1.754160E-01 |
| Stage2-vs-Stage3 |
2.091200E-01 |
| Stage2-vs-Stage4 |
2.144400E-01 |
| Stage3-vs-Stage4 |
9.477400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.777700E-03 |
| Normal-vs-AfricanAmerican |
5.070500E-02 |
| Normal-vs-Asian |
4.545800E-01 |
| Caucasian-vs-AfricanAmerican |
4.802000E-01 |
| Caucasian-vs-Asian |
7.138800E-01 |
| AfricanAmerican-vs-Asian |
8.548200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.642700E-03 |
| Normal-vs-Female |
6.525000E-03 |
| Male-vs-Female |
6.958000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.987950E-02 |
| Normal-vs-Age(41-60Yrs) |
8.095200E-03 |
| Normal-vs-Age(61-80Yrs) |
4.475200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.763550E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.524000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.637000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.175600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.983200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.975400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.948200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.484000E-01 |
| Normal-vs-Grade 2 |
9.014300E-02 |
| Normal-vs-Grade 3 |
1.71381999999332E-05 |
| Normal-vs-Grade 4 |
1.156410E-03 |
| Grade 1-vs-Grade 2 |
9.482200E-01 |
| Grade 1-vs-Grade 3 |
2.422000E-01 |
| Grade 1-vs-Grade 4 |
3.197400E-01 |
| Grade 2-vs-Grade 3 |
3.637900E-03 |
| Grade 2-vs-Grade 4 |
4.680200E-02 |
| Grade 3-vs-Grade 4 |
8.816000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.641560E-01 |
| Normal-vs-ccB subtype |
8.409700E-04 |
| ccA subtype-vs-ccB subtype |
2.807900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.262500E-03 |
| Normal-vs-N1 |
1.361990E-01 |
| N0-vs-N1 |
8.688000E-01 |
|
|
